Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG531 (romiplostim) plus ciclosporin A in previously untreated aplastic anemia
jRCT2080224878Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label, single-arm trial of romiplostim in aplastic anemia, sponsored by Kyowa Kirin. Primary endpoint: hematologic response. Started Sep 2019; status: completed.
02
Drugs
romiplostim
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on jRCT2080224878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224878.